400
Participants
Start Date
May 31, 1998
Primary Completion Date
May 31, 2005
Study Completion Date
May 31, 2005
Idarubicin
Cytosin-Arabinosid
Etoposide
All-trans Retinoid acid
III Medical Department, Hematology and Oncology Center, Hanuschhospital Wien, Vienna
Department of Hematology / Oncology, University Hospital of Innsbruck, Innsbruck
Medical Department III of Hematology and Oncology, General Hospital Altona, Hamburg
Medical Department II, University Hospital of Kiel, Kiel
Department of Hematology and Oncology, Clinical Center of Oldenburg gGmbH, Oldenburg
Medical Department IV, University of Gießen, Giessen
Centre of Interial Medicine, University of Göttingen, Göttingen
Department of Internal Medicine Hematology, Heinrich-Heine University, Düsseldorf
Department of Interial Medicine, Wilhelm-Anton-Hospital Goch, Goch
Department of General Internal Medicine, University Hospital of Bonn, Bonn
Hospital of Barmherzige Brüder, I Medical Department, Trier
Department of Interial Medicine III, City Hospital Frankfurt Am Main - Höchst, Frankfurt
Department of Hematologie and Oncology, Caritas Hospital St. Theresa Saarbrücken, Saarbrücken
Department of Interial Medicine I, University Hospital of Saarland, Homburg
Department of Hematology and Oncology, City Hospital Neunkirchen gGmbH, Neunkirchen
Department of Interial Medicine /Hematology and Oncology, Caritas Hospital Lebach, Lebach
Department of Interial Medicine V, University of Heidelberg, Heidelberg
Clinikal Cetner of Stuttgart, Center of Oncology, Stuttgart
Medical Department I, Clinical Center of Stuttgart, Stuttgart
Medical Department II, City Hospital Karlsruhe gGmbH, Karlsruhe
I. Medical Department, City Hospital München-Schwabing, München
Medical Department III, Clinical Center rechts der Isar, München
University of Ulm
OTHER